Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone plus azithromycin versus ceftriaxone on anorectal resistome in Neisseria gonorrhoeae infection
2021-003616-10Phase 4Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in gonorrhea comparing Ceftriaxone monotherapy with Ceftriaxone plus azithromycin (2 arms). Primary endpoint: Primary. Started Oct 2021; status: completed.
02
Drugs
ceftriaxoneazithromycin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on 2021-003616-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003616-10.